Isoniazid

Isoniazid (INH) is a first-line anti-tuberculosis medication used to treat active tuberculosis infection. It has been used for over 70 years, and is one of the most commonly prescribed drugs for tuberculosis. As INH is bactericidal, it has been shown to reduce mortality from tuberculosis and significantly improve the prognosis of those infected. In addition, it can be used to prevent latent tuberculosis from becoming active. INH is generally well-tolerated, making it a safe and effective treatment for tuberculosis.


From: International Journal of Antibiotic Research

Related Topics

Plagues

Septicemia

Biotechnology Environmental Microbiology

Plasma Cells

Clinical Microbiology

Prescribing Practices

Antibody Production

Related Article For "Isoniazid"

About (1) results

Journal: Preventive Medicine And Care
ISSN: 2474-3585
Editor: Bhoomika Patel, Nirma University, Assistant Professor
Publication Type: Open Access Journal
Description: Preventive Medicine aims to improve the health of individuals and populations through translational research, education and training, community outreach and promotion of public health. It is dedicated to promote health across the lifespan and in all segments of population. We aim to advance the science of health promotion and disease prevention
Aim & Scope
Submit Manuscript
Call For Papers